Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Pharma giant Gilead Sciences again plays the villain in this story but there’s plenty of blame to go around.
The Senate released appropriation bills that cover funding for several HIV programs. Here are the big wins and concerns.
Nearly half of people living with HIV in the United States receive support from the federal Ryan White HIV/AIDS Program.
“You already know and love someone living with HIV” is the message of an anti-stigma campaign in Boston.
The appropriations committee laid out increases in HIV funding for housing, syringe services, health care training and more.
That’s a $267 million increase for HIV efforts from 2021. Plus, Biden’s 2022 budget invests $6.5 billion in health research.
The availability of multiple, low-cost generic versions of PrEP should be good news for access. But will it be?
Here’s how to ensure that critical HIV programs get funded.
People newly qualified for Medicaid saw their access to undetectable viral loads inch up.
The new Avita pharmacy specializes in services related to HIV, PrEP, LGBTQ issues and the 340B Drug Pricing Program.
This represents a new high for HIV-diagnosed people who receive medical care covered by the Ryan White HIV/AIDS Program.
Watch AIDS advocates urge the governor not to abandon efforts to combat HIV, hepatitis and opioid overdoses.
But is it enough? And what about support for syringe services?
The Arlington location is one of over 35 clinics in the South operated by CAN Community Health.
Advocates and lawmakers spoke with AIDS United during the recent political conventions.
One recent survey found that it wasn’t meds.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.